NCT02108106View on ClinicalTrials.gov

A Phase I Study of AG-348 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Healthy Volunteer
Interventions
DRUG

AG-348

A range of doses of AG-348 will be tested based on assessment of safety and tolerability.

DRUG

Placebo

Trial Locations (1)

21225

Baltimore

Sponsors
All Listed Sponsors
lead

Agios Pharmaceuticals, Inc.

INDUSTRY